Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
G.et al
Separate-vial workflow Independent dose control for cagrilintide and semaglutide Use separate vials when you want to escalate cagrilintide and semaglutide on different schedules, hold one compound at a lower dose, or accommodate different vial concentrations
A clear measurement removes guesswork and creates simple math for each use
phase 3 REDEFINE 1 monotherapy arm, n=3,417 total Phase 2, n=263 Trial timepoint 26 weeks (phase 2)
Examples of systemic goals include appetite and glucose regulation (GLP-1 agonists), growth-hormone axis stimulation (CJC-1295 and secretagogues), or systemic tissue repair
US$ 23.46
US$ 27.75
US$ 25.05
US$ 20.16
US$ 29.90
